Poland, July 24 -- Poland based Takeda Pharma Sp. z o.o. has secured contract from Instytut Psychiatrii i Neurologii for Pharmaceutical products - Successful delivery of the drug to the drug program - Agalsidase alfa . The value of the contract is worth 629640 PLN .
Published by HT Digital Content Services with permission from Pivotal Sources....